The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
basically these some of these drugs that are lowering cholesterol through interacting with some of these enzymes or proteins pcsk9 and HMG COA reductases when they have genetic Knockouts or genetic variance basically what you find is these people have increased risk of diabetes which is the side effect profile that you see with cardiovascular disease with the stat or or with the statins
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's also studies looking at people who have HMG COA reductase genetic variant which are the same uh the same enzyme that statins Target and the same we basically also have non-favorable effects